{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-21-000145","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2021-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.021226+00:00","generated_at":"2026-06-30T08:04:19.584562+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BeiGene appoints Julia Wang as CFO; Howard Liang retires effective June 30, 2021","bullets":["Julia Wang named CFO, principal financial and accounting officer, effective June 30, 2021.","Annual base salary $445,000; bonus target 50% of base; equity grants vesting over four years.","Prior CFO Howard Liang retired; no disagreement regarding financial reporting or accounting.","Liang entered 4-month consulting agreement; unvested options continue to vest during term.","Wang previously SVP Enterprise Optimization & Deputy CFO; prior roles at Alexion, Quest, J&J."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-21-000145","json":"https://secwatch.observer/filing/0001651308-21-000145.json","markdown":"https://secwatch.observer/filing/0001651308-21-000145.md","text":"https://secwatch.observer/filing/0001651308-21-000145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/0001651308-21-000145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/bgne-20210630.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T08:04:19.584562+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d8f8ddf7f4","claim":"Howard Liang retired as Chief Financial Officer and Chief Strategy Officer at BeOne Medicines Ltd..","evidence_excerpt":"On June 30, 2021, Howard Liang, Ph.D., Chief Financial Officer and Chief Strategy Officer, retired from the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/0001651308-21-000145-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chief Financial Officer and Chief Strategy Officer"}],"fact_type":"executive_change"},{"claim_id":"e3007ca095","claim":"Julia Wang was appointed as Chief Financial Officer at BeOne Medicines Ltd..","evidence_excerpt":"on June 30, 2021, Julia Wang became the Chief Financial Officer of BeiGene, Ltd.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/0001651308-21-000145-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}